Skip to main content


Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 2/2016

Ausgabe 2/2016

Inhaltsverzeichnis ( 18 Artikel )

24.06.2016 | Review | Ausgabe 2/2016

Weight gain during adjuvant endocrine treatment for early-stage breast cancer: What is the evidence?

K. A. Nyrop, G. R. Williams, H. B. Muss, S. S. Shachar

02.07.2016 | Review | Ausgabe 2/2016

Recurrent and pathological gene fusions in breast cancer: current advances in genomic discovery and clinical implications

Jamunarani Veeraraghavan, Jiacheng Ma, Yiheng Hu, Xiao-Song Wang

21.06.2016 | Preclinical study | Ausgabe 2/2016

Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer

Koung Jin Suh, Han Suk Ryu, Kyung-Hun Lee, Hyojin Kim, Ahrum Min, Tae-Yong Kim, Yaewon Yang, Hyeong-Gon Moon, Sae-Won Han, Do-Youn Oh, Wonshik Han, In Ae Park, Dong-Young Noh, Seock-Ah Im

01.07.2016 | Preclinical study | Ausgabe 2/2016

Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer

Emma E. Bright, Keith J. Petrie, Ann H. Partridge, Annette L. Stanton

27.06.2016 | Preclinical study | Ausgabe 2/2016

Amount of stroma is associated with mammographic density and stromal expression of oestrogen receptor in normal breast tissues

Marike Gabrielson, Flaminia Chiesa, Janna Paulsson, Carina Strell, Catharina Behmer, Katarina Rönnow, Kamila Czene, Arne Östman, Per Hall

29.06.2016 | Preclinical study | Ausgabe 2/2016

GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells

Zi-Jian Lan, YunHui Hu, Sheng Zhang, Xian Li, Huaxin Zhou, Jixiang Ding, Carolyn M. Klinge, Brandie N. Radde, Austin J. Cooney, Jin Zhang, Zhenmin Lei

04.07.2016 | Preclinical study | Ausgabe 2/2016

Sulforaphene inhibits triple negative breast cancer through activating tumor suppressor Egr1

Ming Yang, Wendi Teng, Yue Qu, Haiyong Wang, Qipeng Yuan

05.07.2016 | Preclinical Study | Ausgabe 2/2016

Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer

M. A. Aleskandarany, A. R. Green, I Ashankyty, A Elmouna, M Diez-Rodriguez, C. C. Nolan, I. O. Ellis, E. A. Rakha

06.07.2016 | Preclinical study | Ausgabe 2/2016

Breast fine needle aspiration continues to be relevant in a large academic medical center: experience from Massachusetts General Hospital

Jianyu Dong, Amy Ly, Ronald Arpin, Quratulain Ahmed, Elena Brachtel

01.07.2016 | Clinical trial | Ausgabe 2/2016

Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes

Vassiliki Kotoula, Vasilios Karavasilis, Flora Zagouri, George Kouvatseas, Eleni Giannoulatou, Helen Gogas, Sotiris Lakis, George Pentheroudakis, Mattheos Bobos, Kyriaki Papadopoulou, Eleftheria Tsolaki, Dimitrios Pectasides, Georgios Lazaridis, Angelos Koutras, Gerasimos Aravantinos, Christos Christodoulou, Pavlos Papakostas, Christos Markopoulos, George Zografos, Christos Papandreou, George Fountzilas

02.07.2016 | Clinical trial | Ausgabe 2/2016

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00

Giancarlo Pruneri, Kathryn P. Gray, Andrea Vingiani, Giuseppe Viale, Giuseppe Curigliano, Carmen Criscitiello, István Láng, Thomas Ruhstaller, Lorenzo Gianni, Aron Goldhirsch, Roswitha Kammler, Karen N. Price, Giuseppe Cancello, Elisabetta Munzone, Richard D. Gelber, Meredith M. Regan, Marco Colleoni

01.07.2016 | Epidemiology | Ausgabe 2/2016

Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer

Christine Leopold, Anita K. Wagner, Fang Zhang, Christine Y. Lu, Craig Earle, Larissa Nekhlyudov, Dennis-Ross Degnan, J. Frank Wharam

01.07.2016 | Epidemiology | Ausgabe 2/2016

Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue

Hannah Oh, Clara Bodelon, Maya Palakal, Nilanjan Chatterjee, Mark E. Sherman, Laura Linville, Berta M. Geller, Pamela M. Vacek, Donald L. Weaver, Rachael E. Chicoine, Daphne Papathomas, Deesha A. Patel, Jackie Xiang, Susan E. Clare, Daniel W. Visscher, Carolyn Mies, Stephen M. Hewitt, Louise A. Brinton, Anna Maria V. Storniolo, Chunyan He, Montserrat Garcia-Closas, Stephen J. Chanock, Gretchen L. Gierach, Jonine D. Figueroa

28.06.2016 | Epidemiology | Ausgabe 2/2016

Reproductive factors related to childbearing and mammographic breast density

Lusine Yaghjyan, Graham A. Colditz, Bernard Rosner, Kimberly A. Bertrand, Rulla M. Tamimi

29.06.2016 | Epidemiology | Ausgabe 2/2016

The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer

Mette S. van Ramshorst, Margriet van der Heiden-van der Loo, Gwen M. H. E. Dackus, Sabine C. Linn, Gabe S. Sonke

30.06.2016 | Epidemiology | Ausgabe 2/2016

Axillary evaluation and lymphedema in women with ductal carcinoma in situ

Ellie J. Coromilas, Jason D. Wright, Yongmei Huang, Sheldon Feldman, Alfred I. Neugut, Grace Clarke Hillyer, Ling Chen, Dawn L. Hershman

06.07.2016 | Epidemiology | Ausgabe 2/2016

Impact of a prior diagnosis of DCIS on survival from invasive breast cancer

Victoria Sopik, Javaid Iqbal, Ping Sun, Steven A. Narod

23.06.2016 | Brief Report | Ausgabe 2/2016

Learning from social media: utilizing advanced data extraction techniques to understand barriers to breast cancer treatment

Rachel A. Freedman, Kasisomayajula Viswanath, Ines Vaz-Luis, Nancy L. Keating

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.